Hypersensitivity in muscle pain syndromes

Current Pain and Headache Reports

Volumn 7, Issue 6, 2003, Pages 426-432

  Henriksson, Karl G ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLODYNIA; BIOCHEMISTRY; BRAIN CORTEX; BRAIN STEM; CLINICAL EXAMINATION; FACILITATION; FIBROMYALGIA; HUMAN; HYPERALGESIA; INHIBITORY POSTSYNAPTIC POTENTIAL; MEDICAL RESEARCH; MUSCLE SPINDLE; MYALGIA; NERVE CELL; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE CONDUCTION; NERVE FUNCTION; NERVOUS SYSTEM; NOCICEPTION; NOCICEPTIVE RECEPTOR; PAIN THRESHOLD; PATHOGENESIS; PRESSURE SENSE; REVIEW; SENSITIZATION; SPINAL CORD DORSAL HORN; SYNAPTIC TRANSMISSION; ANIMAL; METABOLISM; METHODOLOGY; MUSCLE DISEASE; PAIN; PAIN ASSESSMENT; PATHOLOGY; SYNDROME;

ANIMALS; HUMANS; HYPERALGESIA; MUSCULAR DISEASES; PAIN; PAIN MEASUREMENT; SYNDROME;

EID: 1542396222     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-003-0058-5     Document Type: Review

References (59)

1. Woolf CJ, Decosterd I: Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain Suppl 1999, 6:141-147.
2. Pfeiffer-Jensen M: Pressure algometry on joints in rheumatoid arthritis. In Computer Controlled Pressure Algometry in Human Joints [PhD Thesis]. Faculty of Health Sciences, Denmark: University of Aarhus Denmark; 1999:1-33.
3. Sörensen J, Graven-Nielsen T, Henriksson KG, et al.: Hyperexcitability in fibromyalgia. J Rheumatology 1998,25:152-155.
4. Kosek E, Ekholm J, Hansson P: Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996, 68:375-383.
5. Lautenbacher S, Rollman GB, McCain GA: Multimethod assessment of experimental and clinical pain in patients with fibromyalgia. Pain 1994, 59:45-53.
6. Rollman GB, Lautenbacher S: Sex differences in musculoskeletal pain. Clin J Pain 2001, 17:20-24.
7. Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1768.
8. Bengtsson A, Henriksson K G, Jorfelddt L, et al.: Primary fibromyalgia: a clinical and laboratory study of 55 patients. Scand J Rheumatol 1986, 15:340-347.
9. Henriksson CH, Carlberg U, Henriksson KG, et al.: Fibromyalgia: Rapport Stimulansbidrag för habilitering och rehabilitering. Swedish National Board of Health and Welfare 2000, ISSN 1403-3348.
10. Lápossy E, Maleitzke R, Hrycaj P, et al.: The frequency of transition of chronic low back pain to fibromyalgia. Scand J Rheumatol 1995, 24:29-53.
11. Clauw DJ, Paul P: The overlap between fibromyalgia and inflammatory rheumatic diseases: when and why does it occur? J Clin Rheumatol 1995, 1:335-341.
12. Buskila D, Neumann L, Vaisberg G, et al.: Increased rates of fibromyalgia following cervical injury: a controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997, 40:446-452.
13. Koelbaek Johansen M, Graven-Nielsen T, Schou Olesen A, Arendt-Nielsen L: Generalized muscular hyperalgesia in chronic whiplash syndrome. Pain 1999, 83:229-334.
14. Buskila D, Neumann L, Hazanov I, Carmi R: Familial aggregation in the fibromyalgia syndrome. Arthritis Rheum 1996, 26:605-611.
15. Pillemer SR, Bradley LA, Crofford LJ, et al.: The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997, 40:1928-1939.
16. Martinez-Lavin M: The autonomic nervous system and fibromyalgia. J Musculoskel Pain 2002, 10:221-228.
17. Chesterton LS, Barlas P, Foster NE, et al.: Gender differences in pressure pain threshold in healthy humans. Pain 2003, 101:259-266.
18. Vecchiet L: Muscle pain and aging. J Musculoskeletal Pain 2002, 10:5-22.
19. Amandusson A, Hermanson O, Blomqvist A: Colocalization of oestrogen receptor immunoreactivity and preproenkephalin MRNA expression to neurons in the superficial laminae of the spinal and medullary dorsal horn of rats. Eur J Neurosci 1996, 8:2440-2445.
20. Buskila D, Neumann L, Odes L R, et al.: The prevalence of musculoskeletal pain and fibromyalgia in patients hospitalized on internal medicine wards. Arthritis Rheum 2001, 30:411-417.
21. Torebjörk HE, Lundberg LE, LaMotte RH: Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiology 1992, 448:765-780.
22. Torebjörk E: Subpopulations of human C nociceptors and their sensory correlates. In Proceedings of the 9th World Congress on Pain: Progress in Pain Research and Management, vol 16. Edited by Devor M, Rowbotham MC, Wiesenfeld-Hallin Z. Seattle: IASP Press; 2000:199-206.
23. Graven-Nielsen T, Mense S: The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin J Pain 2001, 17:2-10.
24. Henriksson KG, Mense S: Pain and nociception in fibromyalgia: clinical and neurobiological considerations on aetiology and pathogenesis. Pain Reviews 1994, 1:245-260.
25. Lund N, Bengtsson A, Thorborg P: Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986, 15:165-173.
26. Larsson B, Björk J, Henriksson KG, et al.: The prevalences of cytochrome c oxidase negative and superpositive fibres and ragged-red fibres in the trapezius muscle of female cleaners with and without myalgia and of female healthy controls. Pain 2000, 84:379-387.
27. Henriksson KG, Bengtsson A, Lindman R, Thornell LE: Morphological changes in muscle in fibromyalgia and chronic shoulder myalgia. In Progress in Fibromyalgia and Myofascial Pain. Edited by Vaeroy H, Merskey H. The Netherlands: Elsevier Science Publishers BV; 1993:61-73.
28. Larsson SE, Ålund M, Cai H, Öberg PÅ: Chronic pain after soft-tissue injury of the cervical spine: trapezius muscle blood flow and electromyography at static loads and fatigue. Pain 1994, 57:173-180.
29. Bengtsson M, Bengtsson A, Jorfeldt L: Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain 1989, 39:171-180.
30. Eneström S, Bengtsson A, Frödin T: Dermal IgG deposits and increase of mast cells in patients with fibromyalgia: relevant findings or epiphenomena? Scand J Rheumatol 1997, 26:308-313.
31. Aspegren Kendall S, Henriksson KG, Hurtig I, et al.: Differences in sensory thresholds in the skin in women with the fibromyalgia syndrome: a comparison between ketamine responders and ketamine non-responders. J Musculoskeletal Pain, in press.
32. Berglund B, Harju EL, Kosek E, Lindblom U: Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 2002, 96:177-187.
33. Mense S: Neurobiological concepts of fibromyalgia: the possible role of descending spinal tracts. Scand J Rheumatol 2000, 29(suppl 113):24-29.
34. Ren K, Dubner R: Descending modulation in persistent pain: an update. Pain 2002, 100:1-6.
35. Vaeroy H, Helle R, Forre O, et al.: Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988, 32:21-26.
36. Russell IJ, Orr MD, Littman B, et al.: Elevated cerebrospinal levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 1994, 37:593-1601.
37. Lindh C, Liu Z, Lyrenäs S, et al.: Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc. Scand J Rheumatol 1997, 26:468-472.
38. Bendtsen L, Nórregaard J, Jensen R, Olesen J: Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 1997, 401:98-102.
39. 2 laser stimulation in subjects with fibromyalgia syndrome. Pain 1994, 58:185-193.
40. Lorenz J, Grasedyck K, Bromm B: Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996, 100:165-168.
41. Price DD, Mao J, Frenk H, Mayer DJ: The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994, 59:165-174.
42. Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, et al.: Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000, 85:483-491.
43. Price DD, Staud R, Robinson ME, et al.: Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 2002, 99:49-59.
44. Sörensen J, Bengtsson A, Bäckman E, et al.: Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995, 14:360-365.
45. Sörensen J, Bengtsson A, Ahlner J, et al.: Fibromyalgia: Are there different mechanisms in the processing of pain? J Rheumatol 1997, 24:1615-1621.
46. Kosek E, Hansson P: Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation [HNCS] in fibromyalgia patients and healthy subjects. Pain 1997, 70:41-51.
47. Kosek E, Ekholm J, Hansson P: Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 1996, 64:415-423.
48. Staud R, Robinson ME, Vierck CJ Jr, Price DD: Diffuse noxious inhibitory controls [DNIC] attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003, 101:167-174.
49. Mountz JM, Bradley LA, Modell JG, et al.: Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995, 38:926-938.
50. Gracely RH, Petzke F, Wolf JM, Clauw DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333-1343.
51. Flor H, Braun C, Elbert T, Birbaumer N: Extensive reorganization of primary somatosensory cortex in chronic back pain patients. Neurosci Lett 1997, 224:5-8.
52. Watkins LR, Milligan ED, Maier SF: Glial activation: a driving force for pathological pain. Trends Neurosci 2001, 24:450-455.
53. Samad TA, Moore KA, Sapirstein A, et al.: Interleukin-1 beta-mediated induction of cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-475.
54. Ek M, Engblom D, Saha S, et al.: Pathway across the blood-brain barrier. Nature 2001, 410:430-431.
55. Rollman GB, Lautenbacher S: Hypervigilance effects in fibromyalgia: pain experience and pain perception. In Progress in Fibromyalgia and Myofascial Pain. Edited by Vaeroy H, Merskey H. The Netherlands: Elsevier Science Publishers B V; 1993:149-159.
56. Keogh E, Mansoor L: Investigating the effects of anxiety sensitivity and coping on the perception of cold pressor pain in healthy women. Eur J Pain 2001, 5:11-25.
57. Crofford LJ, Clauw DJ: Fibromyalgia: Where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum 2002, 46:1136-1138.
58. Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 22:160-172.
59. Mense S, Simons DG, Russell J: Glossary. In Muscle Pain: Understanding Its Nature, Diagnosis, and Treatment. Philadelphia: Lippincott Williams & Wilkins; 2001:339-367.